9
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Intracellular free calcium concentration and thromboxane A2 formation of vascular smooth muscle cells are influenced by fish oil and n-3 eicosapentaenoic acid

, , &
Pages 541-547 | Received 05 Nov 1990, Accepted 07 Apr 1991, Published online: 08 Jul 2009
 

Abstract

The effect of fish oil and n-3 eicosapentaenoic acid (EPA) on intracellular free calcium concentration ([Ca2+]i) and thromboxane B2 (TXB2) formation in resting and stimulated cultured rat vascular smooth muscle cells (VSMC) was examined. In resting control cells [Ca2+]i was 147 ± 15 nmol l-1 (mean ± SEM, n=4). After pretreatment of the cells with fish oil or EPA for 24 days the resting [Ca2+]i was decreased to 126 ± 10 nmol l-l and 84 ± 8 nmol-1, respectively. After stimulation of untreated control cells with either 100 nmol 1-1 angiotensin II (All), 40 μg ml-1 low-density lipoprotein (LDL), or 100 ng ml-1 of recombinant platelet-derived growth factor (PDGFAB), [Ca2+]i was (in nmol 1-1) 306 ± 31, 217 ± 25 and 213 ± 16. Treatment of cells with fish oil or EPA reduced the stimulatory effect of the agonists, and the following [Ca2+]i values (in nmol l-1) were found: 199 ± 21, 131 ± 10, 148 ± 13; and 175 ± 11, 98 ± 12, and 103 ± 6, respectively. PDGFAB induced a four fold increase in TXB2-generation (270 ± 28 pg mg-1 cell protein compared with 61 ± 8.2 pg mg-1 in unstimulated control cells) within 6 min. In cells pretreated with fish oil or EPA, TXB2-formation was reduced by 54% and 44%, respectively. In conclusion: in rat VSMC stimulated by a variety of vasoactive agonists, fish oil and EPA can markedly attenuate intracellular mechanisms related to changes of cytosolic calcium concentration and eicosanoid production. These findings might partly explain, on the subcellular level, the beneficial effects of fish oil on atherosclerosis and hypertension.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.